Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
The three goals under the declaration include improving coordination and data collection, as well as offering better tools to potentially save lives
Officials are pushing to be the first city in the U.S. to have a supervised injection site with a controversial proposal
Each team member has a job, including one to do compressions, one to ventilate and another to medicate
EMS can be a major player in clinical medicine, operational delivery and healthcare changes, decreasing morbidity and mortality
The legislation is expected to include a limit on the first fill of narcotic drugs and a good Samaritan law allowing bystanders to call 911 for help without fear of arrest
Lawmakers hope that mandating use of the state’s prescription monitoring program will reduce drug abuse in Texas
Under the program, if an individual meets certain criteria, the SOBER Unit ambulance will transport that person to the sobering center on skid row
Gov. Andrew Cuomo said the state would sue pharmaceutical companies that violate rules on prescription monitoring and reporting
Officials said drug makers and distributors contributed to a “public health crisis” where patients are turned into addicts to feed corporate greed
Scientists said they have unveiled the structure of a receptor protein as it binds to a morphine-related molecule for the first time
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.